From
http://files.shareholder.com/downloads/ABEA-474G59/4194058620x0xS1564590-17-1314/1476170/filing.pdf
The Company has also engaged a financial advisory firm to further assist with fundraising efforts. -at the same time- the company is restricted by lender as to who it can issue shares to until 30 April 17.
the Company has been evaluating the prospects of its non-wearable injector customer programs and attempting to negotiate terminations of certain non-wearable injector customer contracts- Teneo Touch gone?
The headquarters has a lien on it but may nett around $15 mil if sold.
Amgen could advance the Jan 18 $15 mil early.
Sanofi could buy in
Chapter 7 could result but I believe an administrator would be appointed and assets sold off.
Who ends up with those assets I do not know.
Chapter 11 seems more likely with Orbimed funding but the company could put to the courts and restructure all contracts and I am thinking Sanofi won't come out of this too well.
I believe this will consume the courts for years if SH are shafted.
All IMO
- Forums
- ASX - By Stock
- UNS
- Where are we at
Where are we at, page-8
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)